Stock on Demand This Week: Windtree Therapeutics Inc. (WINT)


Windtree Therapeutics Inc. (NASDAQ:WINT) remained unchanged to close Tuesday at $0.17 after subtracting $0.0 on the day. The 5-day average trading volume is 1,755,460 shares of the company’s common stock. It has gained $0.2351 in the past week and touched a new high 1 time within the past 5 days. An average of 793,130 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 485,396.

The company’s shares have touched a 52-week low of $0.14 and high of $1.44, with the stock’s rally to the 52-week high happening on 01/04/23. However, the current price is down -88.19% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Valuation Metrics

WINT stock has a beta of 0.24. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 0.30.

Windtree Therapeutics Inc.’s quick ratio for the period ended June 29 was 2.50, with the current ratio over the same period at 2.50. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.86, while the total debt to equity was 0.90.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -102.22% to -$4.06 million, while revenue of -$17.33 million was -326.85% off the previous quarter. Analysts expected WINT to announce -$0.18 per share in earnings in its latest quarter, but it posted -$0.59, representing a -227.80% surprise. EBITDA for the quarter stood at more than -$4.17 million. WINT stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 30.68 million, with total debt at $18.28 million. Shareholders hold equity totaling $38.61 million.

Let’s look briefly at Windtree Therapeutics Inc. (WINT) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 38.68% to suggest the stock is trending Neutral, with historical volatility in this time period at 171.03%.

The stock’s 5-day moving average is $0.1882, reflecting a -25.50% or -$0.0582 change from its current price. WINT is currently trading -2.13% above its 20-day SMA, -56.70% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +3.03% and SMA200 by-84.55%.

Stochastic %K and %D was 24.87% and 38.22% and the average true range (ATR) pointed at 0.0247. The RSI (14) points at 42.70%, while the 14-day stochastic is at 27.30% with the period’s ATR at 0.0238. The stock’s 9-day MACD Oscillator is pointing at -0.0323 and -0.0343 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Windtree Therapeutics Inc. (NASDAQ: WINT), Ladenburg Thalmann launched coverage with a Buy rating. Analysts offering their rating for WINT stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate WINT as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.

What is WINT’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $3.00 and a high of $3.00, with their median price target at $3.00. Looking at these predictions, the average price target given by analysts is for Windtree Therapeutics Inc. (WINT) stock is $3.00.


Please enter your comment!
Please enter your name here